We partner with clients to unleash their imagination. Together, we envision more: More breakthroughs. More opportunities to thrive in today's ever-evolving marketplace. Reach out to unlock your full potential:

Imagine More. Together.

#ASCO24 #deerbornedifference

Exciting News! The Deerborne Group will be attending the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago from May 31 - June 4, 2024!  For more info or to schedule a meeting, contact us today!
bit.ly/3wSpjxs

#ASCO24 #deerbornedifference

The Deerborne Group would like to acknowledge all the men and women in uniform who made the ultimate sacrifice while in the service of this great country and say thank you! And to the Gold Star families, God bless you. Happy Memorial Day!

#memorialday2024 #veterans

Cue Health, an at-home provider of lab-quality PCR COVID-19 tests, is shutting down today, May 24, 2024 and laying off all staff following an FDA warning about its test kits' accuracy. Click here to read more: bit.ly/3Veb6V3

#FDA #layoffs #deerbornedifference #ASCO24

🚨 #ASCO24 abstracts are now available!

Late-Breaking Abstracts (LBAs) will be released at 7:00 AM CT on the day of scientific presentation at the meeting. Explore this year's research: brnw.ch/21wK5bj #OncTwitter

Please join us in celebrating Steven's one-year work anniversary with The Deerborne Group. Let’s applaud his dedication and outstanding contributions in helping us become recognized as one of San Diego’s leading management consulting companies! #ImagineMoreTogether

At The Deerborne Group, we recognize the significance of scientific innovation and pioneering solutions that are poised to revolutionize healthcare for generations to come. Contact us today: bit.ly/3TVB3YF !

Imagine More. Together.

#ASCO24 #deerbornediffernece

Karius received an FDA breakthrough designation for its DNA-based blood test detecting over 1,000 pathogens, following a $100 million funding boost. Click here to read more: bit.ly/3V8EPyv

#ImagineMoreTogether #FDA #infectiousdisease #ASCO24 #deerbornediffernece

Karius received an FDA breakthrough designation for its DNA-based blood test detecting over 1,000 pathogens, following a $100 million funding boost. Click here to read more: bit.ly/3V8EPyv

#ImagineMoreTogether #FDA #infectiousdisease
#ASCO24 #deerbornediffernece

FDA warns against using Cue Health's COVID-19 tests due to reliability issues. Dispose of them and retest with a different FDA-authorized brand if symptomatic. Click here to learn more: bit.ly/3QRCZj6

#genomics #nextgenerationsequencing #ASCO24 #deerbornediffernece

At The Deerborne Group, we too share a profound appreciation for pioneering new paths toward scientific innovation. Contact us today to unleash your full potential and let's revolutionize healthcare, together.

#ImagineMoreTogether #genomics #ASCO24 #deerbornediffernece

The US House committee on Oversight and Accountability overwhelmingly approved the Biosecure Act, targeting Chinese biotech firms like BGI and WuXi AppTec over national security concerns. Click here to read more: reut.rs/3WG7FaD

#ASCO24 #deerbornediffernece

We recognize the significance of scientific innovation and pioneering solutions that are poised to revolutionize healthcare. Contact us today to unleash your full potential: bit.ly/3TVB3YF !

Imagine More. Together.

#ImagineMoreTogether #ASCO24 #deerbornediffernece

Feeling like you're stuck in a Déjà vu loop at work? The Deerborne Group, we view the future of the precision diagnostics market through a different lens. Reach out and let's shape this future together! bit.ly/3TVB3YF
#ImagineMoreTogether #deerbornediffernece #ASCO24

Pacific Biosciences, a competitor of Illumina, is closing its San Diego office, laying off nearly 200 workers, and consolidating its research in Menlo Park to save $75 million annually. Click here to read more: bit.ly/4bgfoRa

#genomics #ASCO24 #deerbornedifference

At The Deerborne Group, we too share a profound appreciation for scientific innovation and discovery. Contact us today to unleash your full potential and let's revolutionize healthcare, together.

#ImagineMoreTogether #nextgenerationsequencing #ASCO24 #deerbornediffernece

Cue Health, a venture-backed diagnostic company based in San Diego, CA, previously valued at $2.3 billion, has announced another round of layoffs. Click here to read more: bit.ly/3Wv3777

#layoffs #venturecapital #privateequity #ASCO24 #deerbornedifference

At The Deerborne Group, we view the future of the genomics and precision diagnostics market through a different lens. Reach out and let's shape this future together! Imagine More. Together. Contact us here: bit.ly/3TVB3YF
#ImagineMoreTogether #deerbornediffernece #ASCO24

Frederick Sanger father of genomics could imagine the significance of scientific advancements. At The Deerborne Group, we share a appreciation for scientific innovation and discovery. Contact us today to unleash your full potential.

#ImagineMoreTogether #deerbornediffernece

Are you ready? The NGS market is poised for significant change in the coming years. If you would like a no-charge summary of this report, click here: bit.ly/DeerborneNGSRe…

#nextgenerationsequencing #genomics #marketintelligence #COMPASS360 ° #ASCO24 #Deerbornedifference